Gastric Cancer Biomarkers Identified in New Study
A new research study identifies lncRNAs CBR3-AS1 and PCA3 as significantly overexpressed in gastric cancer tissues.
Read MorePosted by Chris Wolski | Jun 5, 2025 | Unknown Origin & Other Cancer Types |
A new research study identifies lncRNAs CBR3-AS1 and PCA3 as significantly overexpressed in gastric cancer tissues.
Read MorePosted by Chris Wolski | May 21, 2025 | Immunoassay Reagents & test Kits |
The Guardant Hereditary Cancer test is a blood-based genetic screening tool that identifies inherited cancer risk variants.
Read MorePosted by Chris Wolski | May 13, 2025 | Cancer |
Oncologists are seeing more advanced cancer cases due to screening barriers and are concerned current tests aren’t effective enough.
Read MorePosted by Chris Wolski | Apr 30, 2025 | Prostate |
Fellow Health showcased innovative research, emphasizing mail-in semen testing to enhance prostate cancer diagnostics and PVSA care.
Read MorePosted by Chris Wolski | Apr 25, 2025 | Prostate |
Veracyte has launched Decipher Prostate test, a Medicare-covered test for guiding treatment in metastatic prostate cancer.
Read More